Abstract
In this report, we examined plasma stromal cell-derived factor-1 levels in normal healthy donors for allogeneic peripheral blood stem cell transplantation (PBSCT) and in patients for autologous PBSCT using an enzyme-linked immunosorbent assay. The average level of plasma stromal cell-derived factor-1 was 2197pg/ml before granulocyte colony-stimulating factor administration and 1899 pg/ml on day 4, demonstrating a significant decrease in the peripheral blood of healthy donors (P = 0.0003). In patients for autologous PBSCT, a significant decrease of plasma stromal cell-derived factor-1 in the peripheral blood was also observed (P = 0.0464). However, the physiologic gradient of stromal cell-derived factor-1 between peripheral blood and bone marrow was never inverted in normal healthy donors or in autologous PBSCT patients. Our results suggest that stromal cell-derived factor-1 may not be involved in the granulocyte colony-stimulating factor-induced release of CD34+ cells to the peripheral blood. Further studies of a possible additive effect of granulocyte colony-stimulating factor and stromal cell-derived factor-1 are warranted.
| Original language | English |
|---|---|
| Pages (from-to) | 651-654 |
| Number of pages | 4 |
| Journal | Bone Marrow Transplantation |
| Volume | 31 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - Apr 2003 |
Fingerprint
Keywords
- Granulocyte colony-stimulating factor
- Peripheral blood stem cell mobilization
- Stromal cell-derived factor-1
ASJC Scopus subject areas
- Hematology
- Transplantation
Cite this
Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. / Kozuka, T.; Ishimaru, F.; Fujii, Keiko; Masuda, K.; Kaneda, K.; Imai, T.; Fujii, Nobuharu; Ishikura, H.; Hongo, S.; Watanabe, T.; Shinagawa, K.; Ikeda, K.; Niiya, K.; Harada, M.; Tanimoto, M.
In: Bone Marrow Transplantation, Vol. 31, No. 8, 04.2003, p. 651-654.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization
AU - Kozuka, T.
AU - Ishimaru, F.
AU - Fujii, Keiko
AU - Masuda, K.
AU - Kaneda, K.
AU - Imai, T.
AU - Fujii, Nobuharu
AU - Ishikura, H.
AU - Hongo, S.
AU - Watanabe, T.
AU - Shinagawa, K.
AU - Ikeda, K.
AU - Niiya, K.
AU - Harada, M.
AU - Tanimoto, M.
PY - 2003/4
Y1 - 2003/4
N2 - In this report, we examined plasma stromal cell-derived factor-1 levels in normal healthy donors for allogeneic peripheral blood stem cell transplantation (PBSCT) and in patients for autologous PBSCT using an enzyme-linked immunosorbent assay. The average level of plasma stromal cell-derived factor-1 was 2197pg/ml before granulocyte colony-stimulating factor administration and 1899 pg/ml on day 4, demonstrating a significant decrease in the peripheral blood of healthy donors (P = 0.0003). In patients for autologous PBSCT, a significant decrease of plasma stromal cell-derived factor-1 in the peripheral blood was also observed (P = 0.0464). However, the physiologic gradient of stromal cell-derived factor-1 between peripheral blood and bone marrow was never inverted in normal healthy donors or in autologous PBSCT patients. Our results suggest that stromal cell-derived factor-1 may not be involved in the granulocyte colony-stimulating factor-induced release of CD34+ cells to the peripheral blood. Further studies of a possible additive effect of granulocyte colony-stimulating factor and stromal cell-derived factor-1 are warranted.
AB - In this report, we examined plasma stromal cell-derived factor-1 levels in normal healthy donors for allogeneic peripheral blood stem cell transplantation (PBSCT) and in patients for autologous PBSCT using an enzyme-linked immunosorbent assay. The average level of plasma stromal cell-derived factor-1 was 2197pg/ml before granulocyte colony-stimulating factor administration and 1899 pg/ml on day 4, demonstrating a significant decrease in the peripheral blood of healthy donors (P = 0.0003). In patients for autologous PBSCT, a significant decrease of plasma stromal cell-derived factor-1 in the peripheral blood was also observed (P = 0.0464). However, the physiologic gradient of stromal cell-derived factor-1 between peripheral blood and bone marrow was never inverted in normal healthy donors or in autologous PBSCT patients. Our results suggest that stromal cell-derived factor-1 may not be involved in the granulocyte colony-stimulating factor-induced release of CD34+ cells to the peripheral blood. Further studies of a possible additive effect of granulocyte colony-stimulating factor and stromal cell-derived factor-1 are warranted.
KW - Granulocyte colony-stimulating factor
KW - Peripheral blood stem cell mobilization
KW - Stromal cell-derived factor-1
UR - http://www.scopus.com/inward/record.url?scp=0037688166&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037688166&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1703901
DO - 10.1038/sj.bmt.1703901
M3 - Article
C2 - 12692604
AN - SCOPUS:0037688166
VL - 31
SP - 651
EP - 654
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
SN - 0268-3369
IS - 8
ER -